Bone Marrow-derived Stem/Progenitor Cells: Their Use in Clinical Studies for the Treatment of Myocardial Infarction

Heart Lung and Circulation

Volumn 18, Issue 3, 2009, Pages 171-180

  Lasala, Gabriel P ^a   Minguell, José J ^a  

^a TCA Cellular Therapy   (United States)

Author keywords

Bone marrow progenitors; Cellular therapy; Myocardial infarction; Stem cells

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD133 ANTIGEN; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; TECHNETIUM 99M;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW CELL; CELL FUNCTION; CELL ISOLATION; CELL REGENERATION; CELL RENEWAL; CELL SELECTION; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY BYPASS SURGERY; CORONARY STENT; DRUG ELUTING STENT; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FOLLOW UP; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICULOGRAPHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN-STENT RESTENOSIS; INFUSION; INTERMETHOD COMPARISON; INTRACORONARY INFUSION; INTRAMYOCARDIAL INFUSION; INTRAVENOUS ADMINISTRATION; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROENVIRONMENT; MONONUCLEAR CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE REGENERATION; TRANS ENDOCARDIAL INFUSION;

ALDEHYDE DEHYDROGENASE; ANTIGENS, CD; ANTIGENS, CD34; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; GLYCOPROTEINS; HUMANS; INFUSIONS, INTRALESIONAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; PEPTIDES;

EID: 67349123823     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2008.09.007     Document Type: Review

References (76)

1. Strauer B.E., Brehm M., Zeus T., Köstering M., Hernandez A., Sorg R.V., Kögler G., and Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
2. Britten M.B., Abolmaali N.D., Assmus B., Lehmann R., Honold J., Schmitt J., Vogl T.J., Martin H., Schächinger V., Dimmeler S., and Zeiher A.M. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI) mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108 (2003) 2212-2218
3. Stamm C., Westphal B., Kleine H.D., Petzsch M., Kittner C., Klinge H., Schümichen C., Nienaber C.A., Freund M., and Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
4. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Mesquita C.T., Rossi M.I., Carvalho A.C., Dutra H.S., Dohmann H.J., Silva G.V., Belém L., Vivacqua R., Rangel F.O., Esporcatte R., Geng Y.J., Vaughn W.K., Assad J.A., Mesquita E.T., and Willerson J.T. Transendocardial, autologous bone marrow cell transplantation for severe chronic ischemic heart failure. Circulation 107 (2003) 2294-2302
5. Assmus B., Schächinger V., Teupe C., Britten M., Lehmann R., Döbert N., Grünwald F., Aicher A., Urbich C., Martin H., Hoelzer D., Dimmeler S., and Zeiher A.M. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
6. Tse H.F., Kwong Y.L., Chan J.K.F., Lo G., Ho C.L., and Lau C.P. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361 (2003) 47-49
7. Avilés F.F., San Román J.A., García Frade J., Valdés M., Sánchez A., de la Fuente L., Peñarrubia M.J., Fernández M.E., Tejedor P., Durán J.M., Hernández C., Sanz R., and García Sancho J. Intracoronary stem cell transplantation in acute myocardial infarction. Rev Esp Cardiol 57 (2004) 201-208
8. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., Kalantzi M., Herbots L., Sinnaeve P., Dens J., Maertens J., Rademakers F., Dymarkowski S., Gheysens O., Van Cleemput J., Bormans G., Nuyts J., Belmans A., Mortelmans L., Boogaerts M., and Van de Werf F. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
9. Musiałek P., Tracz W., Skotnicki A.B., Zmudka K., Pieniazek P., Walter Z., Szostek M., Majka M., Weglarska D., Zalewski J., Olszowska M., Kostkiewicz M., Pasowicz M., Klimeczek P., and Przewłocki T. Transcoronary stem cell delivery using physiological endothelium-targeting perfusion technique: the rationale and a pilot study involving a comparison with conventional over-the-wire balloon coronary occlusions in patients after recent myocardial infarction. Kardiol Pol 64 (2006) 489-498
10. Obradović S., Rusović S., Balint B., Ristić-Andelkov A., Romanović R., Baskot B., Vojvodić D., and Gligić B. Autologous bone marrow-derived progenitor cell transplantation for myocardial regeneration after acute infarction. Vojnosanit Pregl 61 (2004) 519-529
11. Kang H.J., Kim H.S., Zhang S.Y., Park K.W., Cho H.J., Koo B.K., Kim Y.J., Soo Lee D., Sohn D.W., Han K.S., Oh B.H., Lee M.M., and Park Y.B. Effects of intracoronary infusion of peripheral blood stem cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363 (2004) 751-756
12. Mansour S., Vanderheyden M., De Bruyne B., Vandekerckhove B., Delrue L., Van Haute I., Heyndrickx G., Carlier S., Rodriguez-Granillo G., Wijns W., and Bartunek J. Intracoronary delivery of hematopoietic bone marrow stem cells and luminal loss of the infarct-related artery in patients with recent myocardial infarction. J Am Coll Cardiol 47 (2006) 1727-1730
13. Bartunek J., Vanderheyden M., Vandekerckhove B., Mansour S., De Bruyne B., De Bondt P., Van Haute I., Lootens N., Heyndrickx G., and Wijns W. Intracoronary injection of CD133-positive enriched bone marrow progenitors promotes cardiac recovery after recent myocardial infarction, Feasibility and safety. Circulation 112 Suppl I (2005) I-178-I-183
14. Fernández-Avilés F., San Román J.A., García-Frade J., Fernández M.E., Peñarrubia M.J., de la Fuente L., Gómez-Bueno M., Cantalapiedra A., Fernández J., Gutierrez O., Sánchez P.L., Hernández C., Sanz R., García-Sancho J., and Sánchez A. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 95 (2004) 742-748
15. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D., Arseniev L., Hertenstein B., Ganser A., and Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
16. Schächinger V., Assmus B., Britten M.B., Honold J., Lehmann R., Teupe C., Abolmaali N.D., Vogl T.J., Hofmann W.K., Martin H., Dimmeler S., and Zeiher A.M. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44 (2004) 1690-1699
17. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., Endresen K., Ilebekk A., Mangschau A., Fjeld J.G., Smith H.J., Taraldsrud E., Grøgaard H.K., Bjørnerheim R., Brekke M., Müller C., Hopp E., Ragnarsson A., Brinchmann J.E., and Forfang K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 355 (2006) 1199-1209
18. Schächinger V., Erbs S., Elsässer A., Haberbosch W., Hambrecht R., Hölschermann H., Yu J., Corti R., Mathey D.G., Hamm C.W., Süselbeck T., Assmus B., Tonn T., Dimmeler S., Zeiher A.M., and REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
19. Assmus B., Honold J., Schächinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., Teupe C., Pistorius K., Martin H., Abolmaali N.D., Tonn T., Dimmeler S., and Zeiher A.M. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355 (2006) 1222-1232
20. Chen S.L., Fang W.W., Ye F., Liu Y.H., Qian J., Shan S.J., Zhang J.J., Chunhua R.Z., Liao L.M., Lin S., and Sun J.P. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 92-95
21. Hare J. A double blind, randomized, placebo controlled clinical trial of allogeneic mesenchymal stem cells for the treatment of patients with acute myocardial infarction. Innovation in Intervention, 2007 Summit, American College of Cardiology, New Orleans, USA.
22. Harjula A. Principal Investigator. Combined CABG and stem cell transplantation for heart failure. ClinicalTrials.gov Identifier NCT00418418.
23. Steinwender C., Hofmann R., Kammler J., Kypta A., Pichler R., Maschek W., Schuster G., Gabriel C., and Leisch F. Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction. Am Heart J 151 1296 (2006) e7-e13
24. Briguori C., Reimers B., Sarais C., Napodano M., Pascotto P., Azzarello G., Bregni M., Porcellini A., Vinante O., Zanco P., Peschle C., Condorelli G., and Colombo A. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. Am Heart J 151 (2006) 674-680
25. Yaoita H., Takase S., Maruyama Y., Sato Y., Satokawa H., Hoshi N., Ono N., Igari T., Ohto H., and Yokoyama H. Scintigraphic assessment of the effects of bone marrow-derived mononuclear cell transplantation combined with off-pump coronary artery bypass surgery in patients with ischemic heart disease. J Nucl Med 46 (2005) 1610-1617
26. Beeres S.L., Bax J.J., Dibbets-Schneider P., Stokkel M.P., Fibbe W.E., van der Wall E.E., Schalij M.J., and Atsma D.E. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction. Am J Cardiol 100 (2007) 1094-1098
27. Meyer G.P., Wollert K.C., Lotz J., Steffens J., Lippolt P., Fichtner S., Hecker H., Schaefer A., Arseniev L., Hertenstein B., Ganser A., and Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
28. + selected cells in patients with acute myocardial infarction. ClinicalTrials.gov Identifier NCT00313339.
29. Perin E, Principal Investigator. Intramyocardial injection of autologous aldehyde dehydrogenase-bright stem cells for therapeutic angiogenesis. ClinicalTrials.gov Identifier NCT00314366.
30. Chen S., Liu Z., Tian N., Zhang J., Yei F., Duan B., Zhu Z., Lin S., and Kwan T.W. Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J Invasive Cardiol 18 (2006) 552-556
31. Lasala GP, Principal Investigator. Combination stem cell (mesendo) therapy for utilization and rescue of infarcted myocardium. ClinicalTrials.gov Identifier NCT00548613.
32. Hare JM, Principal Investigator. Safety and effectiveness of human mesenchymal stem cell injections for repairing heart damage in people who have had a heart attack and are undergoing surgery for coronary artery bypass grafting. ClinicalTrials.gov Identifier NCT00587990.
33. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., Leri A., and Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
34. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., and Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
35. Hamano K., Nishida M., Hirata K., Mikamo A., Li T.S., Harada M., Miura T., Matsuzaki M., and Esato K. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J 65 (2000) 845-847
36. Nervi B., Link D.C., and DiPersio J.F. Cytokines and hematopoietic stem cell mobilization. J Cell Biochem 99 (2006) 690-705
37. Grove J.E., Bruscia E., and Krause D.S. Plasticity of bone marrow-derived stem cells. Stem Cells 22 (2004) 487-500
38. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Pasumarthi K.B., Virag J.I., Bartelmez S.H., Poppa V., Bradford G., Dowell J.D., Williams D.A., and Field L.J. Hematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
39. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., and Robbins R.C. Hematopoietic stem cells adopt mature hematopoietic fates in ischemic myocardium. Nature 428 (2004) 668-673
40. Lin G., Finger E., and Gutierrez-Ramos J.C. Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues. Eur J Immunol 25 (1995) 1508-1516
41. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., and Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
42. Liu C., Sun Z., Du X., Chen X., Feng J., and Jia B. Implantation of endothelial progenitor cells into laser-induced channels in rat ischemia hindlimb augments neovascularization. Ann Vasc Surg 19 (2005) 241-247
43. Minguell J.J., and Erices A. Mesenchymal stem cells and the treatment of cardiac disease. Exp Biol Med 231 (2006) 39-49
44. Haider HKh. Bone marrow cells for cardiac regeneration and repair: current status and issues. Expert Rev Cardiovasc Ther 4 (2006) 557-568
45. Allan R., Kass M., Glover C., and Haddad H. Cellular transplantation: future therapeutic options. Curr Opin Cardiol 22 (2007) 104-110
46. Gee A.P. Quality control in bone marrow processing. In: Gee A.P. (Ed). Bone marrow processing and purging: a practical guide (1991), CRC Press, Santa Ana, CA 19-27
47. + blood stem cells derived from a single donor. Cell Prolif 39 (2006) 325-332
48. Hess D.A., Meyerrose T.E., Wirthlin L., Craft T.P., Herrbrich P.E., Creer M.H., and Nolta J.A. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 104 (2004) 1648-1655
49. Guenechea G., Gan O.I., Dorrell C., and Dick J.E. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol 2 (2001) 75-82
50. Danet G.H., Lee H.W., Luongo J.L., Simon M.C., and Bonnet D.A. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion. Exp Hematol 29 (2001) 1465-1473
51. Gangenahalli G.U., Singh V.K., Verma Y.K., Gupta P., Sharma R.K., Chandra R., and Luthra P.M. Hematopoietic stem cell antigen CD34: role in adhesion or homing. Stem Cells Dev 15 (2006) 305-313
52. + hematopoietic progenitor cells: a five dimensional flow cytometric study. Haematologica 83 (1998) 587-592
53. Harvey K., Higgins N., Akard L., Chang Q., Jansen J., Thompson J., Dugan M., Rizzo M.T., and English D. Lineage commitment of HLA-DR/CD38-defined progenitor cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence. J Hematother 6 (1997) 243-252
54. Watts M.J., Somervaille T.C., Ings S.J., Ahmed F., Khwaja A., and Yong K. Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2. 1) and Isolex 300i (v2. 5) clinical scale devices. Br J Haematol 118 (2002) 117-123
55. Mizrak D., Brittan M., and Alison M.R. CD133: molecule of the moment. J Pathol 214 (2008) 3-9
56. + lymphatic/vascular endothelial precursor cells. Blood 101 (2003) 168-172
57. Barber C.L., and Iruela-Arispe M.L. The ever-elusive endothelial progenitor cell: identities, functions and clinical implications. Pediatr Res 59 (2006) 26R-32R 4 Pt 2
58. Milkiewicz M., Ispanovic E., Doyle J.L., and Haas T.L. Regulators of angiogenesis and strategies for their therapeutic manipulation. Int J Biochem Cell Biol 38 (2006) 333-357
59. + selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution. Stem Cells 24 (2006) 2279-2283
60. Gentry T., Foster S., Winstead L., Deibert E., Fiordalisi M., and Balber A. Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy. Cytotherapy 9 (2007) 259-274
61. Minguell J.J., Erices A., and Conget P. Mesenchymal stem cells. Exp Biol Med 226 (2001) 507-520
62. Allers C., Sierralta W.D., Neubauer S., Rivera F., Minguell J.J., and Conget P.A. Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation 78 (2004) 503-508
63. Zhang S., Ge J., Sun A., Xu D., Qian J., Lin J., Zhao Y., Hu H., Li Y., Wang K., and Zou Y. Comparison of various kinds of bone marrow stem cells for the repair of infracted myocardium: single clonally purified non-hematopoietic mesenchymal stem cells serve as a superior source. J Cell Biochem 99 (2006) 1132-1147
64. Ohnishi S., Ohgushi H., Kitamura S., and Nagaya N. Mesenchymal stem cells for the treatment of heart failure. Int J Hematol 86 (2007) 17-21
65. Erices A., Conget P., and Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109 (2000) 235-242
66. Rangappa S., Fen C., Lee E.H., Bongso A., and Sim E.K. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 75 (2003) 775-779
67. Perin EC, Principal Investigator. Safety study of allogeneic mesenchymal precursor cells (MPCS) in subjects with recent acute myocardial infarction. ClinicalTrials.gov Identifier NCT00555828.
68. Johnson P.C., Mikos A.G., Fisher J.P., and Jansen J.A. Strategic directions in tissue engineering. Tissue Eng 13 (2007) 2827-2837
69. Hilton M.J., Tu X., Wu X., Bai S., Zhao H., Kobayashi T., Kronenberg H.M., Teitelbaum S.L., Ross F.P., Kopan R., and Long F. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med 14 (2008) 306-314
70. Tavassoli M., and Minguell J.J. Homing of hemopoietic progenitor cells to the marrow. Proc Soc Exp Biol Med 196 (1991) 367-373
71. Martinez-Agosto J.A., Mikkola H.K., Hartenstein V., and Banerjee U. The hematopoietic stem cell and its niche: a comparative view. Genes Dev 21 (2007) 3044-3060
72. Fedak P.W., Verma S., Weisel R.D., and Li R.K. Cardiac remodeling and failure: from molecules to man (Part I). Cardiovasc Pathol 14 (2005) 1-11
73. Scott R.C., Crabbe D., Krynska B., Ansari R., and Kiani M.F. Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue. Expert oflin drues draviil 5 (2008) 459-470
74. Doyle B., Sorajja P., Hynes B., Kumar A.H.S., Araoz P.A., Stalboerger P.G., Miller D., Reed C., Schmeckpeper J., Wang S., Liu C., Terzic A., Kruger D., Riederer S., and Caplice N.M. Progenitor cell therapy in a porcine acute myocardial infarction model induces cardiac hypertrophy, mediated by paracrine secretion of cardiotrophic factors including TGFb. Stem Cells Dev (2008 Jun 18) [Epub ahead of print]
75. Vulliet P.R., Greeley M., Halloran S.M., MacDonald K.A., and Kittleson M.D. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363 (2004) 783-784
76. Breitbach M., Bostani T., Roell W., Xia Y., Dewald O., Nygren J.M., Fries J.W., Tiemann K., Bohlen H., Hescheler J., Welz A., Bloch W., Jacobsen S.E., and Fleischmann B.K. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110 (2007) 1362-1369